Janney Montgomery Scott
PDLI

Janney Montgomery Scott’s PDL BioPharma, Inc. PDLI Stock Holding History

Janney Montgomery Scott’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-22,916
Closed -$67K – 2091
2018
Q1 		$67K Sell
22,916
-189,103
-89% -$516K ﹤0.01% 1912
2017
Q4 		$581K Buy
212,019
+201,119
+1,845% +$618K 0.01% 1232
2017
Q3 		$37K Sell
10,900
-200
-2% -$556 ﹤0.01% 1812
2017
Q2 		$27K Sell
11,100
-403
-4% -$927 ﹤0.01% 1730
2017
Q1 		$26K Hold
11,503
– – ﹤0.01% 1728
2016
Q4 		$24K Sell
11,503
-23,355
-67% -$65.2K ﹤0.01% 1666
2016
Q3 		$117K Buy
+34,858
New +$111K ﹤0.01% 1459
2016
Q1 		– Sell
-35,904
Closed -$127K – 1481
2015
Q4 		$127K Sell
35,904
-7,535
-17% -$31.5K ﹤0.01% 1297
2015
Q3 		$218K Buy
43,439
+1,746
+4% +$10K 0.01% 1205
2015
Q2 		$268K Sell
41,693
-464
-1% -$3.11K 0.01% 1574
2015
Q1 		$297K Buy
42,157
+9,507
+29% +$68.9K 0.01% 1773
2014
Q4 		$252K Buy
32,650
+1,405
+4% +$11.1K 0.01% 1824
2014
Q3 		$233K Sell
31,245
-1,959
-6% -$18.2K ﹤0.01% 1858
2014
Q2 		$321K Sell
33,204
-727
-2% -$6.48K 0.01% 1570
2014
Q1 		$282K Buy
33,931
+734
+2% +$6.29K 0.01% 1496
2013
Q4 		$280K Buy
33,197
+151
+0.5% +$1.27K 0.01% 1486
2013
Q3 		$263K Buy
+33,046
New +$266K 0.01% 1437

Other funds holding PDLI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Janney Montgomery Scott's PDLI Position: Q2 2018 in Review

Janney Montgomery Scott sold out of PDL BioPharma, Inc. (PDLI) in Q2 2018, closing a stake of 22,916 shares — an estimated $67K sold.

Janney Montgomery Scott first reported a position in PDLI in Q3 2013 and held it in 17 quarters. The position peaked at $581K in Q4 2017. 163 funds tracked by Wall St. Rank hold PDLI as of Q2 2018.

  • Janney Montgomery Scott reported no remaining PDL BioPharma, Inc. position as of Q2 2018 after selling out during the quarter.
  • Janney Montgomery Scott sold 22,916 PDL BioPharma, Inc. shares in Q2 2018, an estimated $67K.
  • Janney Montgomery Scott first reported a position in PDL BioPharma, Inc. in Q3 2013 and held it in 17 quarters.
  • Janney Montgomery Scott's PDL BioPharma, Inc. position peaked at $581K in Q4 2017.
  • 163 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2018.

Based on Janney Montgomery Scott's 13F filing for Q2 2018, filed 24 Jul 2018.